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ABSTRACT 
ADVISOR: Brian Cohen 
 
Human follicle stimulating hormone (hFSH) is a protein hormone responsible for stimulating the 
gonads and is necessary for regulating reproductive systems in both females and males. The actions of 
hFSh are carried out by the hFSH receptor (hFSHR), a seven transmembrane receptor that belongs to the 
G protein-coupled receptor family. Once FSH activates its receptor, the G protein inside the cell that is 
associated with the receptor is activated and starts a cascade of signaling that results in activation of 
protein kinase A (PKA) and the p44/42 MAP kinase (MAPK). The activation of these secondary proteins 
is responsible for follicular stimulation in females and gametogenesis in males and females.  
 Previous work in the Cohen Lab has shown that hFSHR is located in cholesterol and sphingolipid 
enriched microdomains referred to as lipid rafts. These microdomains are detergent resistant membranes 
that “float” in sucrose gradients. Current research is focused on the relevance of hFSHR lipid raft 
residency in the human granulosa cell line hGrC1; focusing in particular on the activation of signal 
transduction pathways by hFSHR. To study this in more detail, we are creating a human granulosa cell 
line where the hFSHR gene has been deleted, known as a knockout mutant. CRISPR (Clustered Regularly 
Interspaced Short Palindromic Repeats) is a revolutionary gene editing technique that can create 
knockouts by precisely targeting a 20 nucleotide sequence of the genome using the Cas9 protein.  This 
knockout line will enable us to study lipid raft residency and signaling of mutant hFSHR proteins in the 
native cell background.  By studying the regulation of hFSHR signaling we hope to learn more about the 
receptor’s function and identify new ways to modulate the receptor for novel approaches to contraception 
or treatment of infertility. 
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Introduction 
 
The endocrine system is integrated with hundreds of different hormones and plays a 
major role in human reproduction and fertility. Human follicle stimulating hormone (hFSH) is a 
gonadotropin responsible for stimulating gonads and is necessary for regulating reproductive 
systems in both females and males (Gougeon, 1998). hFSH is a glycoprotein heterodimer 
released from the anterior pituitary gland and in females it acts on the ovaries (Telikicherla, et al. 
2011 and Desai, et al. 2013). The hormone is primarily responsible for signaling the 
development of follicles and the production of estrogens in females (Figure 1). In males, FSH 
acts on Sertoli cells in the seminiferous tubules to promote spermatogenesis (Thompson, et al. 
2014).  
 
Figure 1: Schematic of FSH Production and Hormonal 
Affects in the Female Human Body (Emanuele et al. 
2003) 
 
        Genetic mutations of the hFSH receptor 
can severely affect gametogenesis as seen in schematic 
diagram of Figure 1 (Thompson et al., 2014). Loss of 
function mutations have been seen to cause ovarian 
dysgenesis (ODG) and primary and secondary 
amenorrhea in females. In males, these mutations lead 
to small testes and impaired spermatogenesis. Further studies of hFSH could eventually lead to 
 6 
therapeutic treatments for female infertility and aspermatogenesis in males (Menon and Menon, 
2014). 
  
 
Figure 2: Overview of FSHR 
gene mutations, polymorphisms, 
and splice variants (Desai et al., 
2013) 
 
The hFSH receptor 
(hFSHR) contains an N-terminal 
extracellular domain that binds 
FSH with high specificity 
(Menon and Menon, 2014). The 
receptor also contains seven 
transmembrane domains and belongs to the g protein-coupled receptor family (GPCR). The 
receptor is attached to a g protein on the inside of the cell (Menon and Menon, 2014). Once FSH 
activates its receptor, the G-protein is then activated and starts a complicated cascade of 
signaling.  
The cell membrane, as we know it, is a fluid-mosaic model. Proteins, receptors, channels 
and other molecules are able to move freely as they wish throughout the membrane. It is made of 
a lipid bilayer, in which the outside phosphate heads are hydrophilic and the lipid tails are 
hydrophobic. 
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Figure 3: A “Normal” Cell Membrane as a lipid bilayer with 
http://biology.tutorpace.com/plasma-membrane-online-tutoring 
 
This idea that the cell membrane is uniform is not correct in reality. There are 
microdomains of the membrane that are enriched in sphingolipid and cholesterol . These 
domains are known as lipid rafts (Brown and London, 2000). Sphingolipids have long, largely 
saturated acyl tails and thus aid in the tight, compactness of these membrane microdomains. 
Cholesterol gives the rafts the phase behavior between the loosely packed disorder state and the 
solid-like gel state (Brown and London, 2000). These microdomains can be isolated because they 
are detergent resistant membranes that float on sucrose gradients. There are also raft markers, 
such as gangliosides GM1 and GM3 and flotillin- 1 and 2 (Zajchowski and Robbins, 2002). 
These proteins can be targeted in immunofluorescence to visualize rafts in cell membrane 
(Brown and London, 2000).  
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Figure 4: Lipid Raft 
Organization (Bio380 
textbook) 
 
Rafts are important for 
cell signaling. There are a 
couple of different theories 
about the significance of rafts 
and signaling. First, certain 
receptors and their secondary signaling proteins can be congregated inside the raft to ensure they 
can activate the signaling cascade as quickly as possible. Similarly, rafts can segregate proteins 
inside and outside the microdomain during sorting (Brown and London, 2000). Secondly, rafts 
might directly affect protein function because of its orderliness.   
Previous work in the Cohen lab has shown that hFSHR are commonly located in lipid raft 
domains. The lab focuses on the importance of rafts and signaling through depletion of 
cholesterol using reagents such as methyl-beta-cyclodextrin. After FSH binds to its receptor, 
adenylyl cyclase is activated to turn ATP into cAMP and p44/42 MAP kinase is activated by 
phosphorylation (Figure 4). The activation of these secondary proteins are responsible for follicle 
stimulation and gametogenesis and thus are important signaling pathways to study.  
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Figure 5: Major Signaling 
Pathways Involved in 
Signal Transduction of 
hFSHR (Leurs, et al., 2005)  
 
 
Genome editing 
allows for the investigation 
of cellular activity with 
respect to a particular 
target. In this case our 
target is the hFSHR. 
CRISPR (clustered regularly interspaced short palindromic repeats) is a new approach to genome 
editing. This revolutionary technique, discovered in association with bacterial “immune 
systems”, has allowed for targeted mutation. We can use this method to create knockouts of the 
FSHR in human granulosa cells, which are immortalized non-luteinized (in which the corpus 
luteum has not formed) human ovary cells. The introduction of a stable knockout of hFSHR in 
hGrC1 cells to the Cohen laboratory is vital in order to continue studies of the receptor and its 
signaling importance to fertility and reproduction. 
 10 
 
Figure 6: CRISPR and Cas9 Gene Editing Technique Schematic 
 
 
Methods 
Cell Culture 
 hGrC1 cells and HEK-293-hFSHRs (HEK-293 cells stably expressing hFSHR) were 
maintained in a confluent monolayer at 37°C and 5% CO2 in 10% MEM media. 
 
Treatment of hGrC1 cells with lipid raft depletion 
Confluent hGrC1 and HEK-293-hFSHR cells were grown in 6 well dishes. Previous 
Cohen Lab experiments have shown that day 4 old hGrC1 cells have the most hFSH receptor 
(Rosie, 2016). We set up the experiment using a 150-minute timeline. The following two tables 
show the arrangement of wells and their respective treatments. We used a sterile Pasteur pipet to 
remove the medium from all wells and changed it to serum free medium. The volume total for all 
wells after treatment was 2 mL. 
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Figure 7: Structure of Methyl-Beta-Cyclodextrin (MBCD), which removes cholesterol 
from the cell membrane, thus depleting lipid rafts. 
https://www.researchgate.net/publication/222573024_Cyclodextrins_and_their_uses_A_r
eview 
 
 Table 1: Outline of the overall experiment for one cell line, plate 1 
Control, time 0 Control, time 5 Control, time 15 
Control, time 30 MβCD, time 0 MβCD, time 5 
 
 Table 2: Outline of the overall experiment for one cell line, plate 2 
MβCD, time 15 MβCD, time 30 Nystatin, time 0 
Nystatin, time 5 Nystatin, time 15 Nystatin, time 30 
*Two experiments to test MβCD and FSH concentration were set up differently than above 
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A 5 mM MβCD solution was prepared for the experimental wells and was added at T-150 
minutes for 2 hour pretreatments. Nystatin pre-treatments were given as a spike for 30 minutes 
before beginning FSH treatments. At T-30 100 µL FSH treatments began and were spiked in the 
proper wells labeled above. After the FSH treatments were complete, the 6-well dishes were put 
on ice to stop the reactions. The samples were harvested in order to obtain protein from all 
samples using lysis buffer and douncing techniques referenced in the Cohen lab manual (Cohen).  
 
Immunoblotting and Chemiluminescence  
Western blotting is a technique in which researchers can identify specific proteins from a 
complex mixture of extracted proteins (Mahmood and Yang, 2012). The mixture is first 
separated by size through gel electrophoresis. The product is then transferred to a nylon 
membrane leaving bands at the protein locations. Lastly, the membrane is incubated with probe 
for a specific molecule through the use of antibodies (Mahmood and Yang, 2012). 
Chemiluminesence visually locates the proteins that the antibodies tagged and thus contain the 
target protein. Phosphorylated proteins after hFSH treatment were visualized using this technique 
to investigate if either cAMP and/or MAPK p44 activation were affected by the drugs. If there 
was no or significantly less phosphorylation compared to naive hGrC1s then we could determine 
if the signaling interference was because of lipid raft depletion. 
Western blots from 10% acrylamide gels were used to analyze the collected proteins. The 
samples were diluted according to the BCA assay to ensure equal loading between lanes.  The 
western blots were probed with antibodies specific to the signaling proteins we were interested in 
investigating.  The most common primary antibodies used were 5 µL p-p44 and p-p38 or p-PKA 
 13 
substrates in 10 mL 5% milk in TBST overnight in the cold room. Then the secondary antibody 
(goat anti-rabbit HRP)was incubated on the blots for 1 hour at room temperature.  
 
Immunofluorescence 
Immunofluorescence on hGrC1 cells was carried out following Professor Danowski’s 
laboratory manual as described in the appendix (Danowski, Cancer Cell Biology, Union College, 
Fall 2016). Membrane permeabilization through surfactants was skipped because we did not 
want to puncture holes in the cell membrane since we were studying hFSHR which reside in the 
membrane. The primary antibody was mAb 106.105 was used at a 1:200 dilution in 1x PBS to 
stain for hFSH receptor. The secondary antibody used was goat anti-mouse Alexa 594 at a 
dilution of 1:300 in 1x PBS. 
 
CRISPR 
Clustered regularly interspaced short palindromic repeats, CRISPR, was derived from 
bacterial immune system and now serves as a revolutionary gene-editing technique (Porteus, 
2016). It utilizes a protein called Cas9 and a guide RNA component, referred to as, sgRNA. Cas9 
has helicase, nuclease, and sgRNA binding activity. CRISPR/Cas9 system is activated 
specifically through RNA-DNA hybridization activity and not protein-DNA like other methods 
of genome manipulation. The sgRNA is a 20 nucleotide target sequence allows for the Cas9 to 
know where to made the DSB and comes right after a PAM sequence NGG (Porteus, 2016).  
Double stranded breaks allow for the cells natural DNA repair mechanisms to fix the 
genome. The RNA polymerase will try to fix the break, but this induces mutations. Eventually 
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after many mutations, functional protein cannot be made anymore, and this there is a gene 
knockout (Porteus, 2016). 
First we figured out which sgRNA sequence to use, utilizing the online sequence analyzer on 
MIT Feng Zhang CRISPR online tool website.  This allowed us to easily identify which segment 
of the FSHR sequence to target which was also near a PAM (protospacer adjacent motif) 
sequence (Figure 8). We grew the Addgene plasmid, pSpCas9(BB)-2A-Puro without the insert 
overnight in E. coli and selected using Ampicillin. Then we followed the mini prep kit to obtain 
purified CRISPR plasmid. We annealed, kinased using BbsI, and ligated the oligonucleotides 
into the plasmid following the Cohen protocol handbook. The ligated plasmid was verified using 
restriction enzyme digests using HinDIII (specific cutter to just the linker) and EcoRI, which 
should have yielded 3 product bands of weights 670, 3235 and 5270 bp. Once we verified this 
we could successfully name this plasmid Psp-Cas9-Bb2APuro hFSHR because it contained our 
linker which would lead Cas9 to create a double stranded DNA break in the FSHR gene of the 
hGrC1 cells. We then obtained Psp-Cas9-Bb2APuro hFSHR DNA by replicating the E. coli 
overnight culture and the mini prep series. We froze a stock solution in the -80˚C freezer. We 
then attempted transfected the Psp-Cas9-Bb2APuro hFSHR plasmid into the native hGrC1 cells 
using Lipofectamine and P3000 reagents. We attempted to select clones by using 2uM 
puromycin media. After failure, we decided to try other reagents such as, Satisfection, Torpedo, 
and Transit. Most cells would die after a few days in the puromycin media.  
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Figure 8: pSpCas9(BB)-2A-Puro Addgene Plasmid and Oligonucleotide Insert and Restriction 
Enzyme Sites 
 
  
      5’-CACCAAGCTTCGAGTCATCCAAAA 
             TTCGAAGCTCAGTAGGTTTTCAAA-5’ 
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Results 
 
Figure 9: hFSH causes redistribution of hFSHR on hGrC1 cells. hGRC1 cells were grown 
on coverslips and then treated with hFSH for 0 (A) or 30 (B) minutes.  Cells were fixed 
without permeabilization and stained with anti-hFSHR mAb 106.105 & Goat anti-mouse 
Alexa 594 antibodies.  Cells in A show a broad distribution on the surface, while cells 
circled in (B) show hFSHR in a more punctate pattern. 
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Immunofluorescence showed that the receptor is indeed localized to the cell membrane 
after hormone treatment. This agreed with previous Team Cohen research that concluded that the 
FSHR resides in lipid rafts of the cell membrane. These results allowed us to continue research 
upon the assumption that the FSHR resides in these microdomains of the cell membrane. 
 
Figure 10: Lipid raft disruption with methyl beta-cyclodextrin (MβCD) alters hFSH 
induced signaling in human granulosa cell line and in HEK293 cells stably expressing 
hFSHR cDNA. Cells (hGRC1 in (A), HEK293-hFSHR in (B)) were treated with MβCD 
as indicated and then treated with varying amounts of hFSH. Cell extracts were probed 
for phosphorylated substrates of protein kinase A (PKA). 
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These results showed that intracellular signaling responses are dependent upon the cell 
type that the receptor resides in. There was a dose response seen in both the hGrC1 and 
HEK293R cells. Upon lipid raft depletion with 5mM MBCD, there was an increase in amount of 
phosphorylated substrates by PKA. Therefore, since the phosphorylated substrates of PKA 
serves as a proxy for cAMP production, we can conclude that there was more intracellular 
production of cAMP in both cell lines upon lipid raft depletion. 
Figure 11: Lipid raft disruption with methyl beta-cyclodextrin (MβCD) alters hFSH 
induced signaling in human granulosa cell line and in HEK293 cells stably expressing 
hFSHR cDNA. Cells (hGRC1 in (A), HEK293-hFSHR in (B)) were treated with MβCD 
as indicated and then treated with varying amounts of hFSH. Cell extracts were probed 
for phospho-p44 MAP kinase. 
  
Unlike the results we saw for cAMP production upon lipid raft depletion, the two cell 
lines differed in their p44/42 MAPK response. After lipid raft depletion, the hGrC1 cells showed 
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an increase in p44/42 MAPK phosphorylation. However, the HEK293R cells showed a relative 
decrease in activated p44/42 MAPK after lipid raft depletion. 
 
   
  
Figure 12: 1% agarose gel of restriction digests run on 6 pSpCas9(BB)-2A-Puro-hFSHR samples 
cut with HinDIII and EcoRI. 
 
 After annealing, kinasing using BbsI and ligation of the pSpCas9(BB)-2A-puro plasmid 
we wanted to see if indeed we created an all-in-one CRISPR plasmid to create an hFSHR 
knockout in hGrC1 cells. We used a 1% agarose gel to separate the plasmid segments after the 
digests. HinDIII only cuts in the sgRNA sequence as seen in Figure 8. If we successfully created 
1     2       3       4      5     6 
Sample Lanes 
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an all-in-one plasmid, there would be 3 plasmid fragments of the following sizes: 670, 3235, 
5270 bp. Five of the 6 samples were successful! 
 
Discussion 
Follicle stimulating hormone receptor is an important target for future fertility medical 
care. Before we can design effective treatments, we need to understand more about hFSHR 
signaling. Our research could explain how to target these receptors by learning more about the 
importance of lipid rafts for proper hFSHR function. Knowledge of the hormone and its receptor 
is critical for hFSHR’s ability to act as a target for medicines for more effective birth control 
drugs or for fertility treatment.  
Our first major conclusion after immunofluorescence and immunoblotting experiments 
was that it is really important to study FSHR in a native cell background in hGrC1 cells. The 
HEK293R cells have shown to differ in their intracellular signaling responses upon lipid raft 
depletion. This means that the receptor mutants being made in the lab should be studied in a 
native cell background to yield research that is physiologically relevant.  
The CRISPR hFSHR knockout plasmid failed to transfect into the hGrC1 cell line. One 
potential source of the issue could be that the concentration of puromycin antibiotic was too 
strong for the cells to stay alive. Previous research suggested 2 uM puromycin, however this was 
not used with hGrC1 cells, so we cannot rule this out as a potential reason why the cells were 
dying.  
Ovarian follicles undergo a hormonally controlled form of apoptosis, known as atresia. 
This process can occur at any point in the follicles development (Matsuda, et al. 2012).  
Deprivation of key survival-promoting factors or stimulation is the main cause of this specific 
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cell death. Gonadotropins are a major cell survival hormone to the granulosa cells of the 
follicles. Activation of cAMP-dependent pathways promote survival of these cells in the ovaries. 
Acting through secondary messenger systems, gonadotropins, coupled with nearby ovarian 
factors can thwart atresia.  
 
Figure 13: Schematic model of the Intracellular signaling in healthy human follicles 
compared to that of atretic follicles. FSH that is secreted from the pituitary is essential for 
granulosa cell survival. (Matsuda, et al. 2012) 
 
In the antral stage of follicle development, follicles become gonadotropin-dependent. 
Follicle stimulating hormone, is the most important cell survival signal for the cells in this stage. 
If CRISPR did knockout the hFSHR gene in the hGrC1 cells, then they were not able to respond 
to FSH. Therefore, because of the absence of this survival signal reaction, the granulosa cells 
might have undergone atresia. However, the stage of follicle development of the hGrC1 cell line 
is unknown. Absence of viable cells supports the hypothesis that the hGrC1 cells are in the antral 
stage.  
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Future Research 
 Team Cohen future research on this project might include temporarily silencing the 
hFSHR gene in the hGrC1 cells. siRNA or shRNA could be utilized in order to investigate if the 
cells can survive without the FSH receptors. If not, this is an insight as to why CRISPR did not 
produce any viable cells.  
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Appendix 
Danowski’s Immunofluorescence Manual Excerpt: 
Reagents: -PBS (phosphate-buffered saline with Ca++ & Mg++, to wash cells & dilute antibodies)  
  -4% paraformaldehyde (labeled PF) in PBS, to fix cells 
-0.1% Triton X-100, a detergent used to permeabilize the cells.  (Without this step, the 
rather large antibody molecules  would be unable to penetrate the plasma 
membrane.) 
-Primary antibody, Use at the indicated dilution. Make up 50 ul of diluted antibody for 
each coverslip. Thus, if you are preparing 2 coverslips, make up exactly 100 ul of 
diluted antibody. 
-Secondary antibody, directed against the primary antibody, and conjugated to a 
fluorophore. The stock solutions of the second antibodies will be provided to you at a 
1:15 dilution. The working dilution is 1:300. 
 -A mounting medium to anchor your coverslips to a glass slide. WEAR GLOVES 
when handling this. 
 
Antibodies **This list might be updated/ changed on the day of the lab.  
Anti-cadherin antibody, made in a mouse. Use at 1:100 
Anti-paxillin antibody, made in a mouse. Use at 1:100 
Anti-alpha-actinin antibody, made in a mouse. Use at 1:100 
Anti-vinculin antibody, made in a mouse. Use at 1:200 
Anti-non-muscle myosin, made in a rabbit. Use at 1:200 
 
 
To Make a Moist Chamber: 
In order to prevent the evaporation of the diluted antibody, we need to incubate the coverslips in a moist 
environment. Place 9 or 10 cm filter paper circles into the bottom AND top of a 100 mm plastic petri dish. 
The larger traditional ‘top’ of the petri dish will be used as the bottom. Moisten thoroughly with distilled 
water, and carefully smooth out the filter paper (i.e. get rid of air bubbles) on the bottom of your moist 
chamber so that the coverslips will lie flat on the filter paper.  
 
 
Cautions:  
WEAR GLOVES when handling Paraformaldehyde (PF) and Alexa-Green PHALLOIDIN 
 PF should be used IN THE FUME HOODs only! 
 Phalloidin is a potent poison. Use it with care. 
 
 NEVER let your coverslips dry out. There should always be some solution on them, either PBS 
or diluted antibody. 
 
 
Procedure  
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 (1) First we must “fix” the cells; we will use a dilute solution of formaldehyde in buffer to kill the cells 
and cross-link all proteins together to hold them in their proper place. In the fume hood, remove 
the medium from your dish of cells, using a plastic transfer pipet, and quickly add approximately 
0.5 ml of PF. (Why quickly? We don’t want the live cells to dessicate before we kill them with 
PF). Move your dishes to the side of the hood.  Incubate 8-10 minutes at RT (room temperature)  
**Never squirt anything directly on the cells. They are fragile! Gently add and remove 
solutions from the sides of the petri dishes. 
(2) When the incubation period is up, remove the PF, place it in the labeled PF waste container, and then 
gently wash the dish 3-4 times with PBS. To do this, fill a transfer pipet up with PBS, and 
carefully and slowly squirt the entire contents into the corner of the dish. Then, pour the solution 
out into a ‘dump beaker’, and immediately add another pipette-ful of PBS. Repeat this 3-4 times, 
leaving the PBS on the cells after the last wash for at least 2 minutes. NEVER let the cells dry 
out—always keep liquid on them. Once you have removed the PF and done one PBS wash, 
return to your lab benches (remember—there should be PBS in the dishes, on the cells) for 
the remaining steps.  
(3) DID NOT PERFORM THIS STEP- needed the cell membrane to stay intact 
Next step—permeabilize the plasma membrane so that the antibodies can enter the cell. Pour off the PBS 
and add enough 0.1% Triton X-100 to cover the bottom of the dish (0.5-1.0 ml), and incubate for 
3 minutes EXACTLY  (3’) at room temperature (RT). 
(4) Wash 3-4 times with PBS. Washing is important! Let cells sit in the last PBS wash for approximately 2'. 
(5) **While you are waiting, make the appropriate dilution of primary antibody in PBS. Remember, you 
need 50 ul of diluted antibody per coverslip. (Hint: if you have 2 coverslips, to prepare with the 
same primary antibody, then make 100 ul of diluted antibody; if you have 3 coverslips, make 150 
ul, etc.) Always keep antibodies on ice-they are proteins, and can denature easily. 
(6) Using forceps, remove coverslip from dish, carefully blot any excess PBS by tipping the coverslip 
onto a small piece of filter paper, and letting the edge of the coverslip touch the paper. Place in a 
moist chamber (see above for instructions on making a moist chamber). Gently add 50 ul of 
diluted antibody to the coverslip with a micropipet. Carefully carry your chamber to the cell 
culture incubator and gently place it on a shelf. Incubate for 30-45' at 37 oC. **Save the empty 
petri dishes that the coverslips were in. Rinse them--you will need them later! 
(9) During this incubation, prepare the Alexa green-phalloidin and the second antibody (either goat-anti 
mouse—Alexa Red, labeled GaM-Red or Goat-anti-rabbit—Alexa Red, labeled GaR-Red). You 
will combine these 2 reagents, and incubate them together, but first, you must calculate the 
appropriate dilution. You want to add exactly 50 ul of solution to each coverslip, and you want the 
final concentration of Alexa green—phalloidin to be 1:100 and the secondary antibody 
concentration to be 1:300. Remember that your stock solutions of these 2 reagents are already 
dilute. First, you need to calculate how much further you need to dilute them.  
(10) After incubation in the first antibody, remove the antibody by tipping the coverslip onto a clean scrap 
of filter paper. Return the coverslip to petri dish pre-filled with fresh PBS, and wash 3-4 times, as 
you did earlier, allowing the coverslips to sit in the last wash for ~1-2 min. 
(11) Place coverslip back in a moist chamber, and add 50 ul of the 2nd antibody to each coverslip. 
Incubate for 30 minutes, in the 37 oC incubator. Label your slides during this incubation. Include 
the date, your initials, cell type and name of protein being localized. (Write small!!) 
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(12) After 30 min, remove antibody as before and wash coverslip thoroughly with PBS 3 times BUT 
THEN do the last wash in dH2O. 
(13) Place one very small drop of mounting medium (Pro-Long Anti-Fade mounting medium) onto a 
clean microscope slide. Carefully dry the back of the coverslip, and any excess water. Invert the 
coverslip onto the mounting medium. In other words, the cells are now bathed in (and protected 
by) the mounting medium. Let harden for ~1 day, and view under the fluorescence microscope. 
